MAML2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 5.05279999951647E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.86611999999364E-05 |
Normal-vs-Stage2 |
4.241900E-04 |
Normal-vs-Stage3 |
2.13999999998382E-06 |
Normal-vs-Stage4 |
1.30640054329945E-10 |
Stage1-vs-Stage2 |
8.094800E-01 |
Stage1-vs-Stage3 |
1.459400E-01 |
Stage1-vs-Stage4 |
4.31790000000598E-05 |
Stage2-vs-Stage3 |
3.855200E-01 |
Stage2-vs-Stage4 |
7.581400E-03 |
Stage3-vs-Stage4 |
4.627600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
9.01579999990076E-07 |
Normal-vs-AfricanAmerican |
1.75153999999456E-05 |
Normal-vs-Asian |
1.97375999999583E-05 |
Caucasian-vs-AfricanAmerican |
6.043400E-01 |
Caucasian-vs-Asian |
2.582000E-03 |
AfricanAmerican-vs-Asian |
6.862600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.77290000352914E-08 |
Normal-vs-Female |
1.672340E-02 |
Male-vs-Female |
1.787800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.66580999999555E-05 |
Normal-vs-Extreme_Weight |
2.28340000019145E-07 |
Normal-vs-Obese |
4.917600E-03 |
Normal-vs-Extreme_Obese |
1.8299399999977E-05 |
Normal_Weight-vs-Extreme_Weight |
9.996400E-01 |
Normal_Weight-vs-Obese |
7.146300E-02 |
Normal_Weight-vs-Extreme_Obese |
4.134600E-01 |
Extreme_Weight-vs-Obese |
3.584100E-02 |
Extreme_Weight-vs-Extreme_Obese |
3.671600E-01 |
Obese-vs-Extreme_Obese |
1.583930E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
7.730000E-02 |
Normal-vs-Age(41-60Yrs) |
5.166600E-04 |
Normal-vs-Age(61-80Yrs) |
9.12650000017834E-08 |
Normal-vs-Age(81-100Yrs) |
2.51790000005414E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.073600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.159400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.759000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.192000E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.301890E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.543200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.47620000004556E-06 |
Normal-VS-Type2 PRCC |
2.78190000035927E-07 |
Normal-VS-KIRP CIMP |
3.420100E-03 |
Normal-VS-Unclassified PRCC |
4.261500E-02 |
Type1 PRCC-VS-Type2 PRCC |
1.249230E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.350400E-01 |
Type1 PRCC-VS-Unclassified PRCC |
2.727600E-01 |
Type2 PRCC-VS-KIRP CIMP |
7.222400E-01 |
Type2 PRCC-VS-Unclassified PRCC |
5.870300E-02 |
KIRP CIMP-VS-Unclassified PRCC |
4.163800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.09650000482631E-08 |
Normal-vs-N1 |
1.44479999997227E-06 |
Normal-vs-N2 |
9.833600E-04 |
N0-vs-N1 |
6.997800E-01 |
N0-vs-N2 |
5.669800E-01 |
N1-vs-N2 |
7.296800E-01 |
|
|